By Selma OransayCan we prevent the progression of endometriosis?
By Selma Oransay
Antalarmin inhibits endometriosis progression by corticotropin realizing hormone receptor 1 in rats.
Key Points Lay Summary
By Özge ÖzkayaWomen with Persistent Pelvic Pain Have a Lower Pain Threshold
By Özge Özkaya
This is the case whether or not they have endometriosis.
Key Points Lay Summary
By Hale Goksever CelikEndometriosis and female pelvic pain in all aspects
By Hale Goksever Celik
Endometriosis should be managed by a personalized approach.
Key Points Lay Summary
By Irem OnurThe relationship between periodontal disease and endometriosis
By Irem Onur
Periodontal disease may be associated with endometriosis.
Key Points Lay Summary
By Serdar BalciClonal Proliferation and Cancer Associated Mutations in normal uterine endometrium and endometriosis
By Serdar Balci
Cancer-associated mutations are already present in normal uterine endometrial glands and glands of endometriosis
Key Points Lay Summary
Vaginal Sexual Intercourse during Menstruation
By Irem Onur
The role of vaginal sexual intercourse during menstruation in the occurrence of endometriosis is controversial.
Key Points Lay Summary
By Demet Candaş GreenHOXA-10 levels are related to infertility in endometriosis patients
By Demet Candaş Green
Low expression of HOXA-10 gene was observed in infertile women with endometriosis
Key Points Lay Summary
Somatic mutations in iatrogenic endometriosis.
By Selma Oransay
Why not iatrogenic endometriosis?
Key Points Lay Summary
By Dr. Youngran ParkMistletoe as a Potential Candidate for Endometriosis Treatment
By Dr. Youngran Park
Mistletoe might have anti-angiogenic activity on endometrial stromal cells
Key Points Lay Summary
Surgical techniques for rectosigmoid endometriosis, and functional outcomes
By Hale Goksever Celik
Conservative surgery including rectal shaving and disc excision can be preferred in patients with intermediate risk for bowel endometriosis due to similarities in improvements of symptoms and recurrence rates with fewer short-term complications.
Key Points Lay Summary
A new theory in the pathogenesis of endometriosis
By Serdar Balci
A comprehensive theory for endometriosis pathogenesis
Key Points Lay Summary
By Murat OsmanDevelopment of Less Invasive Diagnostic Tests for Endometriosis Through Proteomics
By Murat Osman
Current Obstacles In the Development of a Blood Test for Endometriosis
Key Points Lay Summary
By Yu YuLocal inflammation and disease severity in endometriosis
By Yu Yu
No evidence of danger theory in endometriosis pathogenesis
Key Points Lay Summary
By Engin AydinNew scientific evidence supporting robotic surgical approach to ureteric endometriosis
By Engin Aydin
Robotic surgical approach to ureteric endometiosis treatment
Key Points Lay Summary
Conservative Surgery May Be Sufficient to Halt the Development of Deep Endometriosis
By Özge Özkaya
A biological process called collective cell migration may dominate gland invasion in endometriotic lesions and therefore disrupting this process with conservative surgery may be sufficient to halt disease progression.
Key Points Lay Summary
The association of endometriosis and peritoneal malignant mesothelioma
By Irem Onur
Peritoneal malignant mesothelioma rarely occurs in women with endometriosis.
Key Points Lay Summary
Pain Education or Cognitive Therapy Could Help Women with Endometriosis
By Özge Özkaya
Endometriosis treatment should not solely focus on surgery or medication.
Key Points Lay Summary
Is the mystery for progression of endometriosis hiding out in abnormally located endometrial cells?
By Selma Oransay
Women with endometriosis show profusely SSEA1 and nSOX9 basalis-like cells located in the functional layer of secretory phase eutopic endometrium.
Key Points Lay Summary
The role of circulating microRNA's in Endometriosis
By Dr. Youngran Park
Increased circulating miR-370-3p regulates Steroidogenic Factor 1 in Endometriosis
Key Points Lay Summary
Endometriosis-associated pain control by contraceptive implant or intrauterine system
By Hale Goksever Celik
Etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system have similar therapeutic effects in women with endometriosis-associated pelvic pain.
Key Points Lay Summary